Correction

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

BMJ 2004; 328 doi: 10.1136/bmj.328.7441.686-b (Published 18 March 2004)
Cite this as: BMJ 2004;328:686.3

Correction to Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

A wrong reference number persisted to publication of the full version of this article by Michel Marre and colleagues (28 February, pp 495-9). In the fifth paragraph of the Discussion, in the sentence starting “Conversely, only 30% of the diabetic patients…” the reference for the HOPE and MICRO-HOPE studies should be reference 9 (not 11, as stated). The references in the abridged version are correct.

Footnotes

Rapid responses

THIS WEEK'S POLL

Read related article

See previous polls

BMJ most popular